Table 5.
Site | Number of polyps |
|||||
---|---|---|---|---|---|---|
50 μg/kg |
100 μg/kg |
|||||
B(a)P alone | B(a)P + USF | B(a)P + SF | B(a)P alone | B(a)P + USF | B(a)P + SF | |
Proximal | 3 + 1.0 | 4 + 0.9 | 8 + 1.0 | 2 + 0.5 | 7 + 0.9 | 9 + 1.3 |
Mid | 4 + 0.5 | 6 + 1.0 | 11 + 2.0 | 5 + 0.5 | 10 + 1.5 | 14 + 2.0* |
Distal | 6 + 0.8* | 8 + 1.0* | 14 + 2.0* | 9 + 1.5* | 11 + 1.2* | 18 + 1.7* |
Abbreviations: B(a)P, benzo(a)pyrene; SF, saturated fat; USF, unsaturated fat.
Note: Data from USF were given as representative of B(a)P-alone treatment group inasmuch as their numbers were not much different from the unsaturated group.
P < 0.05 when a comparison was made with the polyp numbers in the proximal region.